PALFYDEV
Live / Applied — First extension granted (statement of use) (as of 09 Feb 2026)
What this means for you
Not registered yet, but its 27 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99059993
- Mark type
- Stylized text
- Filed
- 27 Feb 2025
- Published for opposition
- 02 Sept 2025
- Attorney of record
- Danny M. Awdeh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use
Owner
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 10 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2026 — SOU EXTENSION 1 GRANTED
- 09 Feb 2026 — SOU EXTENSION 1 FILED
- 09 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Sept 2025 — PUBLISHED FOR OPPOSITION
- 27 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Aug 2025 — ASSIGNED TO EXAMINER
- 27 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Feb 2025 — NEW APPLICATION ENTERED